Delivery Method: VIA EMAIL WITH READ RECEIPT Reference #: 320-25-61 Product: Drugs Recipient: Recipient Name Mr. Chongjiu Li Recipient Title General Manager Wuxi Medical Instrument Factory […]

Delivery Method: VIA UPS Reference #: 320-25-71 Product: Drugs Recipient: Recipient Name Mr. Phillip A.S. Miller Recipient Title Co-CEO Product Society LLC 13056 Saticoy StreetNorth Hollywood, […]

Delivery Method: VIA EMAIL WITH READ RECEIPT Reference #: 320-25-59 Product: Drugs Recipient: Recipient Name Mr. Jimmy Duivenvoorden Recipient Title Site Manager NWL Netherlands Services B.V. […]

Delivery Method: VIA EMAIL WITH READ RECEIPT Product: Animal & VeterinaryDrugs Recipient: Recipient Name Cameron Muir FishMoxFishFlex/Simple Pet Health LLC 520 South 850 East, Ste A1Lehi, […]

To locate a project or a qualified biomarker go to CDER & CBER’s DDT Qualification Project Search database Web content is updated for consistency with 21st […]

Español 药物安全通讯 Drug Safety Podcasts The FDA Drug Safety Communications posted on this web page are intended to provide important information to patients and health care professionals about […]

Between April 25, 2017, and July 6, 2023, FDA identified 209 cases worldwide (197 domestic) of pruritus after stopping treatment with cetirizine (n=180), levocetirizine (n=27), or […]

On May 15, 2025, the Food and Drug Administration approved retifanlimab-dlwr (Zynyz, Incyte Corporation) with carboplatin and paclitaxel for the first-line treatment of adults with inoperable […]

Opioid addiction and abuse is an immense public health crisis and addressing it is one of the FDA’s highest priorities. In 2019, an average of 38 […]